Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting

OBJECTIVES: The differences of efficacy between each Janus kinase (JAK) inhibitors have not been clarified in the patients with rheumatoid arthritis (RA) in clinical practice. Here, we compared the efficacy between tofacitinib (TOFA) and baricitinib (BARI) in clinical practice. METHODS: The efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Yusuke, Nakano, Kazuhisa, Nakayamada, Shingo, Kubo, Satoshi, Inoue, Yoshino, Fujino, Yoshihisa, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372380/
https://www.ncbi.nlm.nih.gov/pubmed/33827788
http://dx.doi.org/10.1136/annrheumdis-2020-219699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372380/
https://www.ncbi.nlm.nih.gov/pubmed/33827788
http://dx.doi.org/10.1136/annrheumdis-2020-219699

Ejemplares similares